Literature DB >> 8757832

Localization of a yeast-phase-specific gene product to the cell wall in Histoplasma capsulatum.

C H Weaver1, K C Sheehan, E J Keath.   

Abstract

A yeast-phase-specific gene, yps-3, has been identified in the virulent Histoplasma capsulatum strain, G217B. Although DNA sequencing of the genomic yps-3 gene from G217B failed to detect homologies with known proteins, the 5' end of a yps-3 cDNA contained a consensus signal sequence. A 519-bp fragment of the cDNA containing the translational stop codon was linker modified and inserted into the bacterial expression vector, pATH 1. Escherichia coli extracts containing the pATH 1 vector alone expressed a major 34-kDa TrpE polypeptide following induction with indoleacrylic acid, while the pATH 1/yps-3 construct produced a predominant 54-kDa TrpE/yps-3 fusion protein. Polyclonal rabbit sera directed against G217B reacted exclusively with the 54-kDa fusion protein in Western blots (immunoblots); serum samples from three patients with acute pulmonary or disseminated histoplasmosis were also positive. To localize the yps-3 protein within G217B, a monoclonal antibody (MAb 7.1) which recognized the yps-3 portion of the fusion protein was generated. A 17.4-kDa protein was detected with MAb 7.1 in Western blots prepared from cell wall fractions of G217B; cytoplasmic fractions were unreactive. No yps-3 antigen was detected in either fraction of the Downs strain, which fails to express the yps-3 gene. MAb 7.1 also detected a 17.4-kDa antigen in ethanol-precipitated culture supernatants derived from G217B. These findings localize the yps-3 gene product to the cell wall and culture supernatants, where the protein may influence the phase transition or the maintenance of the yeast state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757832      PMCID: PMC174186          DOI: 10.1128/iai.64.8.3048-3054.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12.

Authors:  R K Appleyard
Journal:  Genetics       Date:  1954-07       Impact factor: 4.562

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Rapid and efficient cosmid cloning.

Authors:  D Ish-Horowicz; J F Burke
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice.

Authors:  F J Gomez; A M Gomez; G S Deepe
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum.

Authors:  E D Spitzer; B A Lasker; S J Travis; G S Kobayashi; G Medoff
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells.

Authors:  G S Deepe
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

View more
  8 in total

Review 1.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

2.  RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

3.  Surface localization of the Yps3p protein of Histoplasma capsulatum.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Eukaryot Cell       Date:  2005-04

4.  Expression and interstrain variability of the YPS3 gene of Histoplasma capsulatum.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Eukaryot Cell       Date:  2007-03-02

5.  Histoplasma virulence and host responses.

Authors:  Mircea Radu Mihu; Joshua Daniel Nosanchuk
Journal:  Int J Microbiol       Date:  2011-10-05

6.  Dimorphism and Dissemination of Histoplasma capsulatum in the Upper Respiratory Tract after Intranasal Infection of Bats and Mice with Mycelial Propagules.

Authors:  Roberto O Suárez-Álvarez; Jorge H Sahaza; Miriam Berzunza-Cruz; Ingeborg Becker; Everardo Curiel-Quesada; Armando Pérez-Torres; María Del Rocío Reyes-Montes; Maria Lucia Taylor
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

7.  Immunoproteomics Reveals Pathogen's Antigens Involved in Homo sapiens-Histoplasma capsulatum Interaction and Specific Linear B-Cell Epitopes in Histoplasmosis.

Authors:  Marcos Abreu Almeida; Rodrigo Almeida-Paes; Allan Jefferson Guimarães; Richard Hemmi Valente; Célia Maria de Almeida Soares; Rosely Maria Zancopé-Oliveira
Journal:  Front Cell Infect Microbiol       Date:  2020-10-29       Impact factor: 5.293

8.  Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling.

Authors:  Rajagopal N Aravalli; Shuxian Hu; Jon P Woods; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2008-07-07       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.